Cardiovascular Pharmacotherapy
Essential resources on cardiovascular pharmacotherapy
Improving lives across the cardiovascular pharmacotherapy spectrum
Advancing the science and practice of cardiovascular drug therapy
Cardiovascular pharmacotherapy focuses on how medications influence the heart and blood vessels to improve cardiovascular function and reduce disease-related risks. It examines how the body processes these agents, how they act on cardiovascular tissues, and how they can be used safely and effectively within clinical care. This field also includes understanding interactions, patient responses and strategies for optimising therapeutic outcomes in cardiovascular conditions.
Explore an array of resources to deepen your knowledge and support your career within this specialty.
ESC CLINICAL PRACTICE GUIDELINES
Guidelines for evidence-based pharmacotherapy
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
The current Guidelines for the management of cardiovascular disease and pregnancy support health care professionals to manage and care for women with cardiovascular diseases before, during and after pregnancy.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published since the 2019 version, up until 31 March 2025.
Congresses and Events
Cardiovascular pharmacotherapy events and meetings
Educational resources
Educational resources on cardiovascular pharmacotherapy
EHJ – Cardiovascular Pharmacotherapy
The official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy – dedicated to interpreting and integrating new scientific developments to advance pharmacological treatment for patients with cardiovascular disease.
Our resources on ESC 365
Discover resources from our previous events.
Cardiovascular Pharmacotherapy
Recommended Reading
Communities
Belong, connect and grow with our global community
We’re committed to advancing the field of cardiovascular pharmacotherapy.
With a membership of more than 600 professionals, our ESC Working Group on Cardiovascular Pharmacotherapy is an active community dedicated to promoting and supporting all areas of cardiovascular pharmacotherapy.
Not a member yet?
Joining the Working Group on Cardiovascular Pharmacotherapy offers numerous benefits for healthcare professionals.
You can gain access to:
You can enjoy:
Webinars
Pharmacology research, insights and advice, available on-demand
Learn about the latest science and thinking with our cardiovascular pharmacotherapy webinars, covering a wide range of topics across the breadth of cardiovascular drug therapy.
Loading content...
Online learning
Dedicated pharmacotherapy training
Elevate your expertise with our educational training programme covering everything from understanding regulatory approval to implementing pharmacotherapy in daily practice.
Loading content...
Podcasts
Listen and learn with ESC Cardio Talk
Tune into ESC Cardio Talk, your perfect companion on cardiovascular science, which regularly features key pharmacotherapy advances, plus the latest risk management and treatment strategies.
Loading content...
Our volunteers
A global network of dedicated experts
Our ESC Working Group on Cardiovascular Pharmacotherapy is community of expert volunteers, drawn from diverse backgrounds and career stages. By fostering a collaborative environment, we continually work to advance research, knowledge and clinical practice.
Professor Bianca Rocca
Chairperson-Elect of the ESC Working Group on Cardiovascular Pharmacotherapy 2024-2026
Professor Juan Carlos Kaski
Past-Chairperson of the ESC Working Group on Cardiovascular Pharmacotherapy 2024-2026
Professor Dobromir Dobrev
Chairperson of the ESC Working Group on Cardiovascular Pharmacotherapy 2024-2026
Professor Stefan Agewall
Editor-in-Chief of EHJ-Cardiovascular Pharmacotherapy